Alzheimer's research & therapy
Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study.
Che-Yuan Wu, Wajd Alkabbani, Baiju R Shah, Moira K Kapral, Jodi D Edwards, Colleen J Maxwell, Walter Swardfager
Published: 202510.1186/s13195-025-01929-x
No abstract available for this study.